Loading
Latest filing published 06 Dec 2022 for Yumanity Therapeutics, INC., €5,006. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael D. Wyzga appears in our data through filings on Kineta, Inc./de shares, published by SEC (Form 4). The record holds 3 filings, for trades running from 1 December 2021 to 2 December 2022.
On the market, this insider has only sold: 2 sales, €8,213 in total. Besides market trades, the filings include 1 share grant. Since January 2022: no purchases and 2 sales on the market.
The record was last updated on 6 December 2022 with an open-market sale (€5,006) in Kineta, Inc./de. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations